Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [(18)F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression

Despite the anti-proliferative and survival benefits from tumor treating fields (TTFields) in human glioblastoma (hGBM), little is known about the effects of this form of alternating electric fields therapy on the aberrant glycolysis of hGBM. [(18)F]FDG is the most common radiotracer in cancer metab...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neoplasia
Egile Nagusiak: Patel, Chirag B., Beinat, Corinne, Xie, Yuanyang, Chang, Edwin, Gambhir, Sanjiv S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689378/
https://ncbi.nlm.nih.gov/pubmed/33221711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2020.11.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak